BridgeMD
New treatment option for Sexual Wellness
Official title The Effect of Lemongrass on Aerobic Performance
ClinicalTrials.gov ID: NCT07195240
What this study is testing
- What it's testing
- The goal of this experimental study is to examine the influence of Lemongrass extract on aerobic training parameters following a 6-week training programme in males. A secondary aim will be to explore the influence on sexual wellness.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 60, men only. Healthy volunteers may be eligible.
You may be able to join if
- Age ≥ 40 and ≤ 60 years.
- Body Mass Index (BMI) ≥ 19 and ≤ 35 kg/m2.
- Willingness and ability to comply with the protocol in the opinion of the Investigator.
- Judged by the Investigator to be in good health as assessed by a health screening questionnaire.
- Currently identifies as the same biological sex as at birth.
You likely can't join if
- A history of heart disease.
- Any disease that might interfere with the absorption of nutrients (e.g. Chron's disease, celiac disease).
- Recent musculoskeletal or soft tissue injury (within the last 3 months).
- The habitual use of medication that is antihypertensive or antidiabetic medication or might inhibit the ability to complete the study participation.
- Alcohol Intake of greater than 21 units per week.
- A change in bodyweight of more than 3kg within the month preceding the study.
See the full eligibility criteria
- Age ≥ 40 and ≤ 60 years.
- Body Mass Index (BMI) ≥ 19 and ≤ 35 kg/m2.
- Willingness and ability to comply with the protocol in the opinion of the Investigator.
- Judged by the Investigator to be in good health as assessed by a health screening questionnaire.
- Currently identifies as the same biological sex as at birth.
- Currently deemed to be between a physical activity status of sedentaryy to moderately trained (Meet World Health Organization minimum activity guidelines: Adults aged 18-64 years old completing at least 150 to 300 min...
- Have a blood pressure \< 140/90 mmHg.
- A history of heart disease.
- Any disease that might interfere with the absorption of nutrients (e.g. Chron's disease, celiac disease).
- Recent musculoskeletal or soft tissue injury (within the last 3 months).
- The habitual use of medication that is antihypertensive or antidiabetic medication or might inhibit the ability to complete the study participation.
- Alcohol Intake of greater than 21 units per week.
- A change in bodyweight of more than 3kg within the month preceding the study.
- Currently following a weight-loss or weight-gain programme.
- Any known bleeding disorder or reaction to withdrawal of blood samples
The study team makes the final eligibility decision.
Where it's taking place
- Newcastle upon Tyne, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 25 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Newcastle upon Tyne, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.